American Tinnitus Association | Committed to a Cure.

Welcome to ATA's Blog!

ATA posts breaking research news and developments and quickly answers the communities' questions about the condition.

The Prevalence of Tinnitus in the United States and the Self-Reported Efficacy of Various Treatments

Post date: 11/03/11 11:48 am

Sergie Kochkin, Ph.D., from The Better Hearing Institute, Richard Tyler, Ph.D., from the University of Iowa, and Jennifer Born, American Tinnitus Association Director of Public Affairs and Tinnitus Today editor, collaborated to determine the prevalence of tinnitus in a nationally representative sample of more than 46,000 households—the largest survey of its kind.

Summary of Findings

Auction to Silence Tinnitus Starts Today!

Post date: 10/22/11 12:29 pm

Each year, ATA hosts an auction of celebrity memorabilia to raise awareness, and more importantly, to raise funds supporting our mission: curing tinnitus through the development of resources that advance tinnitus research. These auctions are held at times when ATA has a sufficient number of items to generate interest from the broader community.

Neuromonics Receives Contract from U.S. Army to Study Treatment

Post date: 10/20/11 7:36 am

Neuromonics, Inc., the maker and distributor of the Oasis, an FDA-cleared, patented and clinically proven medical device designed for long-term significant relief of tinnitus, has received a $700,000 contract from the U.S. Army to study the effects and use of the Neuromonics Tinnitus Treatment (NTT) in military environments.

Positive Preliminary Results from AM-101 Study

Post date: 10/17/11 3:12 pm

Preliminary results from Auris Medical's phase IIB study show that the local treatment with AM-101 was very well tolerated, and in particular that it had no negative impact on hearing.

Pilot Study Evaluates Ecological Momentary Assessment of Tinnitus

Post date: 10/07/11 9:15 am

ATA Scientific Advisory Committee member Jim Henry's study on a new way to view and evaluate the daily effects of chronic tinnitus, via personal digital assistant, was recently published.

Ryan Adams Reflects on New Album, Ménière's and Tinnitus

Post date: 10/07/11 8:14 am

Ryan Adams didn't write a song or even play a guitar for a year and a half. He was trying to recover his hearing, diminished by tinnitus and Ménière's disease, an inner-ear disorder that also causes dizziness and pain. "I just heard this sort of sound fog. Like a radio station had gone off the air," he recalls.

Acoustic-Trauma Induced Tinnitus Prevented in an Animal Model

Post date: 10/05/11 3:09 pm

A new study involving ATA Board Member Carol Bauer, M.D., and recent Scientific Advisory Committee member Tom Brozoski, Ph.D., showed that bilateral dorsal DCN (dorsal cochlear nucleus) lesions made before high-level noise exposure prevented the development of tinnitus.

New Findings From Phase 1B Study of OTO-104

Post date: 09/29/11 7:31 am

Otonomy, Inc., a clinical stage biopharmaceutical company, presented study data demonstrating that both the 3 mg and 12 mg OTO-104 doses were associated with improvement in tinnitus as measured by the Tinnitus Handicap Inventory (THI-25).

CDC New Powertools Sound Rating Database

Post date: 09/08/11 12:10 pm

The Centers for Disease Control and Prevention (CDC) has a new powertools database that lists the decibel ratings of common powertools from 18 manufacturers and contains downloadable exposure files.

Advances in Treating Tinnitus and Understanding this Increasingly Common Hearing Disorder to be Presented at UB Conference

Post date: 08/10/11 10:16 am

University at Buffalo research showing that a new drug that eliminated tinnitus with a single dose in animal models is among the advances that will be presented at the Fifth Tinnitus Research Initiative Conference, "The Neuroscience of Tinnitus," sponsored by UB's Center for Hearing and Deafness Aug. 19-21 in Grand Island, N.Y.